Projects per year
Personal profile
Personal profile
Dr Mingming Xu received his PhD degree from Griffith University, Australia. Before joining Xi’an Jiaotong-Liverpool University, he did postdoctoral research at Soochow University for over two years. His previous researches include development of fluorescent probes for the diagnosis of Alzheimer’s disease, mass spectrometry-based discovery of small molecule inhibitors against alpha-synuclein aggregation, and discovery of biomarkers for Parkinson’s disease and pancreatic cancer via glycoproteomics.Dr Xus current research interests focus on mass spectrometry-based discovery of clinical biomarkers for common neurodegenerative diseases, identification of exosomal biomarkers from biofluids for human common cancers, and understanding the pathogenesis of Parkinson’s disease.
Research interests
Drug discovery and mechanism study for common neurodegenerative diseases
Identification of exosomal biomarkers from biofluids for common cancers
Mass spectrometry-based biomarker discovery
Experience
Assistant Professor, Academy of Pharmacy, Xi’an Jiaotong-Liverpool University, 2023 to Present
Postdoctoral research fellow, College of Pharmaceutical Sciences, Soochow University, 2020 to 2023
Teaching
APH107 Key Skills for Pharmaceutical Sciences II
APH106 Key Skills for Pharmaceutical Sciences I
Awards and honours
2021, Jiangsu Province-Supported Postdoctoral Research Fellow
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
PhD, Griffith University, 2020
MSc, University of Chinese Academy of Sciences, 2015
BSc, Anhui Normal University, 2012
Person Types
- Staff
Fingerprint
Collaborations and top research areas from the last five years
Projects
- 1 Active
-
N-Glycosylation profiling of pancreatic cancer and mechanistic study of the relations between AMG-510 and glycosylation
1/07/23 → 30/06/25
Project: Internal Research Project
-
Mass spectrometry analysis of intact protein N-glycosylation signatures of cells and sera in pancreatic adenocarcinomas
Xu, M., Liu, Z., Hu, W., Han, Y., Wu, Z., Chen, S., Xia, P., Du, J., Zhang, X., Hao, P., Xia, J. & Yang, S., 8 Jan 2024, In: Journal of Zhejiang University: Science B. 25, 1, p. 51-64 14 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Importance of N-Glycosylation for the Expression and Function of Human Organic Anion Transporting Polypeptide 2B1
Xu, M., 1 Sept 2023, In: ACS Pharmacology & Translational Science.Research output: Contribution to journal › Article › peer-review
3 Citations (Scopus) -
Mass Spectrometric Analysis of Urinary N-Glycosylation Changes in Patients with Parkinson’s Disease
Xu, M., 7 Sept 2023, In: ACS Chemical Neuroscience. 14, 18, p. 3507-3517Research output: Contribution to journal › Article › peer-review
3 Citations (Scopus) -
Protein glycosylation in urine as a biomarker of diseases
Xu, M., Yang, A., Xia, J., Jiang, J., Liu, C. F., Ye, Z., Ma, J. & Yang, S., Mar 2023, In: Translational Research. 253, p. 95-107 13 p.Research output: Contribution to journal › Review article › peer-review
15 Citations (Scopus) -
α-Synuclein Aggregation Inhibitory Procerolides and Diphenylalkanes from the Ascidian Polycarpa procera
Prebble, D. W., Holland, D. C., Hayton, J. B., Ferretti, F., Jennings, L. K., Everson, J., Xu, M., Kiefel, M. J., Mellick, G. D. & Carroll, A. R., 24 Mar 2023, In: Journal of Natural Products. 86, 3, p. 533-540 8 p.Research output: Contribution to journal › Article › peer-review
4 Citations (Scopus)